Umesh Setty V resigns as Caplin Point Labs Senior Vice President, RnD (Formulations)
Chennai: Caplin Point Labs has informed in a BSE filing that Umesh Setty V, Senior Vice President, R&D (Formulations), a Senior Management Personnel (SMP) of the Company, has resigned due to personal reasons.
"The Company has identified suitable replacement who will join in due course," Caplin stated.
Umesh joined Caplin Point Labs in 2018. Prior to this, he worked at Ajanta Pharma, Intas Pharma and Aurobindo Pharma.
Caplin Point Laboratories Limited is a pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. The Company has state of the art manufacturing facilities that cater to a complete range of finished dosage forms.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.